Chemoinformaics analysis of 2,5-Dimethyl-3-(1-propenyl)pyrazine
Molecular Weight | 148.209 | nRot | 1 |
Heavy Atom Molecular Weight | 136.113 | nRig | 11 |
Exact Molecular Weight | 148.1 | nRing | 1 |
Solubility: LogS | -5.265 | nHRing | 1 |
Solubility: LogP | 4.387 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 25.2315 |
nHD | 0 | BPOL | 14.3185 |
QED | 0.669 |
Synth | 4.441 |
Natural Product Likeliness | 2.563 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.383 |
MDCK | 0.0000166 |
BBB | 0.964 |
PPB | 0.920391 |
VDSS | 1.49 |
FU | 0.0605263 |
CYP1A2-inh | 0.171 |
CYP1A2-sub | 0.696 |
CYP2c19-inh | 0.088 |
CYP2c19-sub | 0.936 |
CYP2c9-inh | 0.233 |
CYP2c9-sub | 0.571 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.659 |
CYP3a4-inh | 0.198 |
CYP3a4-sub | 0.515 |
CL | 9.579 |
T12 | 0.063 |
hERG | 0.011 |
Ames | 0.024 |
ROA | 0.21 |
SkinSen | 0.035 |
Carcinogencity | 0.196 |
EI | 0.107 |
Respiratory | 0.521 |
NR-Aromatase | 0.016 |
Antiviral | No |
Prediction | 0.909522 |